Found: 22
Select item for more details and to access through your institution.
The role of liver kinase B1 in tumor progression through regulation of lipid metabolism.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2045, doi. 10.1007/s12094-022-02863-2
- By:
- Publication type:
- Article
MiRNAs in renal cell carcinoma.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2055, doi. 10.1007/s12094-022-02866-z
- By:
- Publication type:
- Article
AMPK's double-faced role in advanced stages of prostate cancer.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2064, doi. 10.1007/s12094-022-02874-z
- By:
- Publication type:
- Article
Colorectal cancer-derived exosomes and modulation KRAS signaling.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2074, doi. 10.1007/s12094-022-02877-w
- By:
- Publication type:
- Article
Long non-coding RNA signatures and related signaling pathway in T-cell acute lymphoblastic leukemia.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2081, doi. 10.1007/s12094-022-02886-9
- By:
- Publication type:
- Article
Bone loss induced by cancer treatments in breast and prostate cancer patients.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2090, doi. 10.1007/s12094-022-02872-1
- By:
- Publication type:
- Article
Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2107, doi. 10.1007/s12094-022-02873-0
- By:
- Publication type:
- Article
CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2120, doi. 10.1007/s12094-022-02881-0
- By:
- Publication type:
- Article
Effect of cell density on the malignant biological behavior of breast cancer by altering the subcellular localization of ANXA2 and its clinical implications.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2136, doi. 10.1007/s12094-022-02865-0
- By:
- Publication type:
- Article
Timing of radiotherapy in glioblastoma based on IMRT and STUPP chemo-radiation: may be no need to rush.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2146, doi. 10.1007/s12094-022-02867-y
- By:
- Publication type:
- Article
Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01).
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2155, doi. 10.1007/s12094-022-02868-x
- By:
- Publication type:
- Article
BMI1 promotes the proliferation and inhibits autophagy of breast cancer cells by activating COPZ1.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2166, doi. 10.1007/s12094-022-02869-w
- By:
- Publication type:
- Article
Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2175, doi. 10.1007/s12094-022-02870-3
- By:
- Publication type:
- Article
Characteristics of gut microbiota in patients with gastric cancer by surgery, chemotherapy and lymph node metastasis.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2181, doi. 10.1007/s12094-022-02875-y
- By:
- Publication type:
- Article
Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic target.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2191, doi. 10.1007/s12094-022-02879-8
- By:
- Publication type:
- Article
The application value of CDFI and SMI combined with serological markers in distinguishing benign and malignant thyroid nodules.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2200, doi. 10.1007/s12094-022-02880-1
- By:
- Publication type:
- Article
Resveratrol inhibits TGF-β1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2210, doi. 10.1007/s12094-022-02882-z
- By:
- Publication type:
- Article
IL-6 secretion of CD4<sup>+</sup> T cells stimulated by LC3-positive extracellular vesicles in human epithelial ovarian cancer.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2222, doi. 10.1007/s12094-022-02883-y
- By:
- Publication type:
- Article
Establishment of an acquired lorlatinib-resistant cell line of non-small cell lung cancer and its mediated resistance mechanism.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2231, doi. 10.1007/s12094-022-02884-x
- By:
- Publication type:
- Article
Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancer.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2241, doi. 10.1007/s12094-022-02887-8
- By:
- Publication type:
- Article
Correction to: Bone loss induced by cancer treatments in breast and prostate cancer patients.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice